[5] Early adjuvant therapy -- replacing tamoxifen therapy with aromatase inhibitor therapy during the first 5 years after surgery; Early sequential adjuvant therapy -- sequencing of tamoxifen and ...

Cognitive dysfunction has been considered as a morbid condition that may possibly result from aromatase inhibitor therapy, the standard treatment in postmenopausal, estrogen/progesterone receptor ...

Swiss pharma giant Novartis AG NVS reported better-than-expected results for the fourth quarter of 2024. Core earnings ...

Novartis AG NVS, a Swiss pharma giant, is scheduled to report fourth-quarter 2024 and full-year results on Jan. 31, 2025. The ...

aCancer Research UK, Centre for Epidemiology, Mathematics, and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary School of Medicine and Dentistry, University of London, London, UK ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...

such as injectable fulvestrant – sold by AZ as Faslodex and the only SERD approved for breast cancer – or aromatase inhibitors like letrozole, anastrozole, or exemestane. For the overall group ...

A deadly collision between an Army helicopter and a commercial airplane at Ronald Reagan National Airport in Washington has claimed 67 lives, including Indian-origin passengers Vikesh Patel and ...

And that is ultimately what compels us to list the greatest films of all-time. It’s not to assert our own canon, or spark quibbles about snubs and arbitrary rankings. It’s because new film ...

Enhertu may cause serious side effects. The following list may not include all possible serious side effects of the drug. For more information, you can refer to Enhertu’s prescribing information.

In 1952, the Sight and Sound team had the novel idea of asking critics to name the greatest films of all time. The tradition became decennial, increasing in size and prestige as the decades passed.

16 HCPs also used their platforms to share news of the FDA’s approval of the drug in combination with an aromatase inhibitor (AI) for the treatment of HR+/HER2 early breast cancer, following the ...